Related Experiment Video
Updated: Aug 18, 2025

In Vivo Immunogenicity Screening of Tumor-Derived Extracellular Vesicles by Flow Cytometry of Splenic T Cells
Published on: September 23, 2021
Extracellular Vesicles and Their Roles in the Tumor Immune Microenvironment
Antonia Reale1, Tiffany Khong1, Andrew Spencer1,2,3
1Myeloma Research Group, Australian Centre for Blood Diseases, Central Clinical School, Monash University-Alfred Health, Melbourne, VIC 3004, Australia.
Extracellular vesicles (EVs) from tumor cells mediate intercellular communication, promoting immune evasion and immunosuppression in cancer. Further research is needed to translate these findings into clinical applications for cancer treatment.
Area of Science:
- Oncology
- Immunology
- Cell Biology
Background:
- Tumor cells release extracellular vesicles (EVs) containing proteins, lipids, and RNA.
- EVs facilitate intercellular communication and modulate recipient cell functions.
- EVs contribute to the tumor microenvironment (TME) and immune suppression in cancer.
Purpose of the Study:
- To review current knowledge on the roles of EVs in tumor immune evasion and immunosuppression.
- To highlight the clinical utility of EV-mediated immunosuppression targeting and EV engineering.
- To discuss the controversial roles, limitations, and future perspectives of EVs in cancer biology.
Main Methods:
- Comprehensive literature review of recent research on EVs in cancer.
- Analysis of studies investigating EV roles in solid tumors and hematological malignancies.
- Examination of EV-mediated immunosuppression and EV engineering for clinical applications.
Main Results:
- EVs promote TME changes and immunosuppressive functions of various immune cells.
- EVs play a significant role in tumor immune escape and propagation.
- EVs offer potential targets for cancer therapy through immunosuppression modulation.
Conclusions:
- EVs are crucial mediators of tumor immune evasion and immunosuppression.
- Translational research in EVs is essential for clinical application.
- Further investigation into EV biology and engineering is needed for effective cancer therapies.
More Related Videos
10:09Characterization of Immune Cell-derived Extracellular Vesicles and Studying Functional Impact on Cell Environment
Published on: June 2, 2020
11:15A Preclinical Mouse Model of Osteosarcoma to Define the Extracellular Vesicle-mediated Communication Between Tumor and Mesenchymal Stem Cells
Published on: May 6, 2018
Related Concept Videos
The Tumor Microenvironment
Tumor Immunotherapy
Overview of Exosomes
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Mesenchymal Stem Cells